These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22705814)

  • 1. Problems of stopping trials early.
    Guyatt GH; Briel M; Glasziou P; Bassler D; Montori VM
    BMJ; 2012 Jun; 344():e3863. PubMed ID: 22705814
    [No Abstract]   [Full Text] [Related]  

  • 2. Current controversies in data monitoring for clinical trials.
    Pocock SJ
    Clin Trials; 2006; 3(6):513-21. PubMed ID: 17170035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The POISE study].
    Rolfo F; Bobbio M; Angeli F; Cavallini C
    G Ital Cardiol (Rome); 2008 Dec; 9(12):803-7. PubMed ID: 19119689
    [No Abstract]   [Full Text] [Related]  

  • 4. Frequentist evaluation of group sequential clinical trial designs.
    Emerson SS; Kittelson JM; Gillen DL
    Stat Med; 2007 Dec; 26(28):5047-80. PubMed ID: 17573678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A decision rule for sequential monitoring of clinical trials with a primary and supportive outcome.
    Zhao Y; Grambsch PM; Neaton JD
    Clin Trials; 2007; 4(2):140-53. PubMed ID: 17456513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bisoprolol prevents mortality and myocardial infarction after vascular surgery.
    Dickerson LM; Carek PJ
    J Fam Pract; 2000 Mar; 49(3):203-4. PubMed ID: 10735475
    [No Abstract]   [Full Text] [Related]  

  • 7. Early viewing of noninferiority trials in progress.
    Dignam JJ
    J Clin Oncol; 2005 Aug; 23(24):5461-3. PubMed ID: 16027438
    [No Abstract]   [Full Text] [Related]  

  • 8. Design of randomized controlled trials.
    Stanley K
    Circulation; 2007 Mar; 115(9):1164-9. PubMed ID: 17339574
    [No Abstract]   [Full Text] [Related]  

  • 9. The ethics of early stopping rules: who is protecting whom?
    Cannistra SA
    J Clin Oncol; 2004 May; 22(9):1542-5. PubMed ID: 15117977
    [No Abstract]   [Full Text] [Related]  

  • 10. The ethics of early stopping rules.
    Pater J; Goss P; Ingle J; Shelley W; Shepherd L
    J Clin Oncol; 2005 Apr; 23(12):2862-3; author reply 2863-4. PubMed ID: 15838002
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-blocker therapy and risk reduction in non-cardiac surgery].
    Passamonti E; Pirelli S
    Ital Heart J Suppl; 2003 Feb; 4(2):96-101. PubMed ID: 12762258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perioperative beta-blockade in patients undergoing noncardiac surgery.
    Ashton JN; Hatton KW; Flynn JD; Smith KM
    Orthopedics; 2010 Jul; 33(7):488-91. PubMed ID: 20608602
    [No Abstract]   [Full Text] [Related]  

  • 13. Setting up a beta-blocker protocol to prevent cardiac complications.
    Mathias JM
    OR Manager; 2005 May; 21(5):1, 8-10. PubMed ID: 15945469
    [No Abstract]   [Full Text] [Related]  

  • 14. Discussion of paper by Korn and Freidlin.
    Wittes J
    Am J Bioeth; 2011 Mar; 11(3):13-4. PubMed ID: 21400376
    [No Abstract]   [Full Text] [Related]  

  • 15. Inefficacy interim monitoring procedures in randomized clinical trials: the need to report.
    Korn EL; Freidlin B
    Am J Bioeth; 2011 Mar; 11(3):2-10. PubMed ID: 21400374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When an interim analysis of randomized trial changes the practice in oncology: The lesson of adjuvant trastuzumab and the HERA trial.
    De Rossi C; Brunello A; Jirillo G; Jirillo A
    Immunopharmacol Immunotoxicol; 2009; 31(1):1-4. PubMed ID: 19238693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Activated protein C, coagulation, inflammation and treatment of severe sepsis].
    Ott A
    Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2196-7. PubMed ID: 11727624
    [No Abstract]   [Full Text] [Related]  

  • 18. Strength of accumulating evidence and data monitoring committee decision making.
    George SL; Freidlin B; Korn EL
    Stat Med; 2004 Sep; 23(17):2659-72. PubMed ID: 15316949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dilemma of data-safety monitoring: provision of significant new data to research participants.
    Peppercorn J; Buss WG; Fost N; Godley PA
    Lancet; 2008 Feb; 371(9611):527-9. PubMed ID: 18262043
    [No Abstract]   [Full Text] [Related]  

  • 20. Continuous safety monitoring for randomized controlled clinical trials.
    Piller LB; Silverman MH; Ball G
    Contemp Clin Trials; 2011 Sep; 32 Suppl 1():S1. PubMed ID: 21458597
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.